top of page
  • Facebook
  • Pinterest
Writer's pictureOmran Aburayya

The Science Diversity Leadership Award (SDLA 2025) By Chan Zuckerberg Initiative | 1.15 Million Grant

The Chan Zuckerberg Initiative invites applications for the Science Diversity Leadership Award.

The Science Diversity Leadership Award (SDLA) is a five-year funding grant (2025–2030) that supports excellent biomedical researchers with a record of promoting diversity, equity, and inclusion in their scientific field.

 

Overview

The Science Diversity Leadership Award (SDLA) from the Chan Zuckerberg Initiative (CZI) will support Principal Investigators who are outstanding early- to mid-career biomedical researchers at U.S. universities, medical schools, or nonprofit research institutes who—through their outreach, mentoring, teaching, and leadership—have a record of promoting diversity, equity, and inclusion (DEI) in their scientific communities.

They will have made significant research contributions to the biomedical sciences, show promise for continuing scientific achievement, and demonstrate leadership in efforts to diversify the sciences. CZI is committed to supporting representative science, which ensures universal benefits from scientific advances, such as studies of diseases that adversely affect underserved populations from specific ancestries, and promotes diversity among researchers toward more inclusive and comprehensive outcomes.

 

About the Award

Each award consists of a $1.15 million USD grant distributed over five years ($230,000 total costs per year, including 15% for indirect costs) to the institution of selected awardees. The grant is to support the awardee’s research program with reasonable flexibility on how these funds are utilized, provided that funds are used to support the awardee’s overall academic program. CZI will convene a mixture of in-person and virtual meetings for which SDLA grantees are expected to participate.

 

Eligibility and Requirements

1. Degree: Applicants must hold an MD, PhD, ScD, MD/PhD, DDM, DVM, or equivalent degree.


2. Position: Applicants should have a faculty position or equivalent independent investigator status at a college, university, medical school, or other research facility.


3. Experience: Applicants should have been in their first independent position for at least three years and less than ten years as of the opening of the Letter of Intent application.


4. Leadership in DEI: Applicants must demonstrate a record of promoting DEI (Diversity, Equity, and Inclusion) through their outreach, mentoring, teaching, and leadership.


5. Research Contributions: Applicants should have made significant research contributions to the biomedical sciences and show promise for continuing scientific achievement.


6. Institutional Support:

Applicants must provide evidence of institutional support, such as a letter from a department chair or equivalent.

 

Application Procedure

The application process for the Science Diversity Leadership Award (SDLA) by the Chan Zuckerberg Initiative (CZI) involves a two-step process:


1. Letter of Intent (LOI)

  • Submission*: Applicants must first submit a Letter of Intent (LOI) by the specified deadline.

  • Evaluation: The LOIs will be reviewed, and finalists will be invited to proceed to the next stage.


2. Full Application

  • Invitation: Finalists from the LOI stage will be invited to submit a full application.

  • Application Components: The full application includes sections such as Applicant Profile, Personal Information, Optional Information, Uploads (including NIH Biosketch, Significant Scientific Contributions essays, and Letters of Reference), and an Institutional Approval Form.

  • Submission: The completed application must be submitted by the final deadline.


🗓️ Application Deadline: Letters of Intent (LOIs) due by December 3, 2024, 5 p.m. Pacific Time.


🌐ℹ️ For complete details about the Award, Requirements, Application process and more, visit the official webpage of The Science Diversity Leadership Award (SDLA) by clicking button below.

 

🔗LINK

 

Comments


bottom of page